Home
Home

Regeneron

Regeneron Shareholders Watching Optina Trial Closely

Regeneron Shareholders Watching Optina Trial Closely
Seeking Alpha

New Asthma Drug Generates Excitement For Patients -- And Its Maker

New Asthma Drug Generates Excitement For Patients -- And Its Maker
Forbes

Leading Biotechs Act Well But Be Careful Not To Chase

Leading Biotechs Act Well But Be Careful Not To Chase
Investors.com

Regeneron: Solid Q1 Creates Platform For Further Upside

Regeneron: Solid Q1 Creates Platform For Further Upside
Seeking Alpha

Regeneron Pharma raises sales forecast for Eylea

Regeneron Pharma raises sales forecast for Eylea
Yahoo/AP

Regeneron Pharmaceuticals Inc.: Today's Featured Health Care Winner

Regeneron Pharmaceuticals Inc.: Today's Featured Health Care Winner
The Street

Regeneron acquires full rights to two novel development programs from Sanofi

Regeneron acquires full rights to two novel development programs from Sanofi
Yahoo/Fly on the Wall

Regeneron Pharmaceuticals Earnings Preview: Can This Streak Continue?

Regeneron Pharmaceuticals Earnings Preview: Can This Streak Continue?
Wall St. Cheat Sheet

Allergan shares fall on delay of eye drug study

Allergan shares fall on delay of eye drug study
Yahoo/AP

Regeneron execs score $140M payday as Eylea mints money

Regeneron execs score $140M payday as Eylea mints money
Fierce Pharma